M

MoonLake Immunotherapeutics
NASDAQ:MLTX

Watchlist Manager
MoonLake Immunotherapeutics
NASDAQ:MLTX
Watchlist
Price: 51.06 USD -1.6%
Market Cap: 3.3B USD
Have any thoughts about
MoonLake Immunotherapeutics?
Write Note

MoonLake Immunotherapeutics
Total Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

MoonLake Immunotherapeutics
Total Assets Peer Comparison

Comparables:
ADCT
ACIU
CRSP
MOLN
XLS

Competitive Total Assets Analysis
Latest Figures & CAGR of Competitors

Company Total Assets CAGR 3Y CAGR 5Y CAGR 10Y
M
MoonLake Immunotherapeutics
NASDAQ:MLTX
Total Assets
$526.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ADC Therapeutics SA
NYSE:ADCT
Total Assets
$354.8m
CAGR 3-Years
-12%
CAGR 5-Years
19%
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
Total Assets
CHf237.5m
CAGR 3-Years
4%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Total Assets
$2.3B
CAGR 3-Years
-7%
CAGR 5-Years
26%
CAGR 10-Years
N/A
Molecular Partners AG
SIX:MOLN
Total Assets
CHf170.6m
CAGR 3-Years
-6%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Xlife Sciences AG
SIX:XLS
Total Assets
CHf512m
CAGR 3-Years
40%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is MoonLake Immunotherapeutics's Total Assets?
Total Assets
526.5m USD

Based on the financial report for Dec 31, 2023, MoonLake Immunotherapeutics's Total Assets amounts to 526.5m USD.

What is MoonLake Immunotherapeutics's Total Assets growth rate?
Total Assets CAGR 1Y
585%

Over the last year, the Total Assets growth was 585%.

Back to Top